Postdocs Organize For Changes

GRIM OUTLOOK: Postdocs need to realize that the odds of getting tenure-track academic jobs are poor, says CSPT's Catherine Gaddy. The once-predictable world of scientific postdoctoral research appears to be entering a period of transformation. Increasingly left in an employment limbo by shrinking tenure-track faculty positions at universities, science postdocs around the United States are beginning to organize and clamor for change. But for many, a nonacademic career seems unavoidable. "The c

Written bySteve Bunk
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


GRIM OUTLOOK: Postdocs need to realize that the odds of getting tenure-track academic jobs are poor, says CSPT's Catherine Gaddy.
The once-predictable world of scientific postdoctoral research appears to be entering a period of transformation. Increasingly left in an employment limbo by shrinking tenure-track faculty positions at universities, science postdocs around the United States are beginning to organize and clamor for change. But for many, a nonacademic career seems unavoidable.

"The current cohort is caught in a difficult time," acknowledges Catherine Gaddy, executive director of the Washington, D.C.-based Commission on Professionals in Science and Technology (CPST). "I think postdocs need information, and we're doing what we can to let them know that the odds [of obtaining a tenure-track position] are wrenching."

CPST, a participating organization of the Washington, D.C.-based American Association for the Advancement of Science (AAAS), analyzes human resource information concerning science and technology as one of its main ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies